Showing results (151-160 of 542) with videos related to
Sort By:
Pageof 55
The Journal of Cell Biology|July 1, 1994
Upregulation of the low density lipoprotein receptor at the blood-brain barrier: intercommunications between brain capillary endothelial cells and astrocytesB Dehouck, M P Dehouck, J C Fruchart, et al.The American Journal of Medicine|June 6, 1994
Fluvastatin reduces levels of plasma apo B-containing particles and increases those of LpA-I. European Fluvastatin Study GroupJ Dallongeville, J C Fruchart, P Pfister, et al.Neurochemical Research|December 1, 1989
Intramyelinic conversion of cerebrosides into acylgalactosylceramidesN Theret, J M Bourre, J C Fruchart, et al.Journal of Internal Medicine. Supplement|January 1, 1994
Effect of fluvastatin on plasma apolipoprotein-B-containing particles, including lipoprotein(a). European Fluvastatin Study GroupJ Dallongeville, J C Fruchart, P Pfister, et al.Journal of Cardiovascular Risk|January 27, 1999
Alpha-tocopherol but not beta-tocopherol inhibits thrombin-induced PKC activation and endothelin secretion in endothelial cellsF Martin-Nizard, A Boullier, J C Fruchart, et al.The Journal of Biological Chemistry|March 5, 1993
Structural properties of high density lipoprotein subclasses homogeneous in protein composition and sizeA Leroy, K L Toohill, J C Fruchart, et al.Metabolism: Clinical and Experimental|June 1, 1996
Very-low-density lipoprotein of uremic patients is a poor substrate for bovine lipoprotein lipase in vitroM Arnadottir, J Dallongeville, J C Fruchart, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|January 13, 1989
Characterization of two monoclonal antibodies to human apolipoprotein A-I that also bind to rabbit apolipoprotein A-I. Application to ELISA evaluation of rabbit serum apo A-IA Leroy, P Olivier, N Vu-Dac, et al.Current Opinion in Lipidology|June 1, 1997
Peroxisome proliferator-activated receptors, orphans with ligands and functionsK Schoonjans, G Martin, B Staels, et al.Journal of Internal Medicine|November 29, 2007
Peroxisome proliferator-activated receptors--from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular diseaseM A Bouhlel, B Staels, G Chinetti-GbaguidiPageof 55